美国 · 平台与数据 · MarketBeat

Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study

来源：MarketBeat · 美国 2 小时前

Amgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to…

在 MarketBeat 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)

Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study

推荐阅读

1 Red Flag That Keeps Me From Buying AMD Stock

Yemen’s Houthis renew threat against Riyadh airport as flights set to resume

Musk says Ukraine violated Starlink terms with offensive drone strikes

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Hercules Capital (HTGC) Stock Still Looks Undervalued After A 63% Five Year Run

Bank of America resets Tesla forecast as Robotaxi miles double

Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study

分享

推荐阅读

1 Red Flag That Keeps Me From Buying AMD Stock

Yemen’s Houthis renew threat against Riyadh airport as flights set to resume

Musk says Ukraine violated Starlink terms with offensive drone strikes

My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?

Hercules Capital (HTGC) Stock Still Looks Undervalued After A 63% Five Year Run

Bank of America resets Tesla forecast as Robotaxi miles double